Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, ...

Table 1. CRC Key Targets for CAR-T Cell Therapy and Their Associated Clinical Trials CDH17 CHM-2101 The United States Phase I/II CAR-T therapy targeting CDH17 in advanced colorectal, gastric, and ...

A new research paper was published in Oncotarget's Volume 16 on January 21, 2025, titled "Assessment of cfDNA release dynamics during colorectal cancer surgery." Researchers from the University of ...